Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

48.90
Delayed Data
As of Feb 05
 -0.75 / -1.51%
Today’s Change
41.87
Today|||52-Week Range
60.34
-15.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues4.1B3.7B4.0B4.0B
 
 
 
 
 
Cost of Goods Sold589.9M477.0M477.9M479.8M
 
 
 
 
 
Depreciation And Amortization74.4M98.5M96.4M94.5M
 
 
 
 
 
 
Operating ExpensesGross Income3.4B3.2B3.5B3.4B
 
 
 
 
 
General Expenses1.9B1.5B1.7B1.7B
 
 
 
 
 
Research And Development642.1M482.8M451.7M490.9M
 
 
 
 
 
Total Operating Expenses2.6B2.1B2.2B2.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.5B1.6B1.8B1.8B
 
 
 
 
 
Extraordinary Credit0.00353.0M--0.00
 
 
Extraordinary Charge-79.7M------
 
 
Interest Expense On Debt--246.1M254.0M276.6M
 
 
 
 
Other Expenses-23.8M102.6M22.6M35.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.4B1.9B1.6B1.5B
 
 
 
 
 
Income Taxes---387.6M-328.1M-261.7M
 
 
 
 
Net Income1.1B1.5B1.2B1.3B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6B2.6B2.6B2.6B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.6B2.6B2.6B
 
 
 
 
 
 
Earnings Per ShareEPS$0.42$0.56$0.48$0.49
 
 
 
 
 
EPS Diluted$0.42$0.56$0.48$0.49